Santiago Fontes, Medical Oncologist, Immuno-Oncology Specialist, shared a post on LinkedIn:
“Thrilled to share that our research on early-onset colorectal cancer has been accepted for presentation at ESMO Gastrointestinal Cancers Congress in Munich, Germany
This work contributes to the growing body of evidence addressing the unique biological and clinical characteristics of early-onset disease, an area of increasing global relevance.
Grateful to have the opportunity to present our findings in this leading international forum addressing GI Malignancies
Looking forward to the discussions ahead and to continuing advancing our understanding of this evolving challenge.”
Other articles featuring Santiago Fontes on OncoDaily.